| Affiliation: | 1. Medicine and Research Dept., German Breast Group (GBG) Forschungs GmbH, Neu-Isenburg, Germany;2. Oncology & Radiotherapy, Medical University of Gdansk, Gdansk, Poland;3. Oncology Department, Tel Aviv Sourasky Medical Center-(Ichilov), Tel Aviv, Israel;4. Clinical Trials Support Unit, Institut Jules Bordet, Brussels, Belgium;5. Yale Cancer Center, Yale University School of Medicine - Yale Cancer Center, New Haven, CT, USA;6. Department of Oncology-Pathology, Karolinska Institutet and Breast Cancer Centre, Cancer Theme, Karolinska University Hospital, Stockholm, Sweden;7. Biostatistics, Dana Farber Cancer Institute, Boston, MA, USA;8. Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland;9. Medicine Dept., Hematology/Medical Oncology Division, Samsung Medical Center (SMC) - Sungkyunkwan University School of Medicine, Seoul, Republic of Korea;10. Surgery Dept., NTUH - National Taiwan University Hospital, Taipei, Taiwan;11. Oncologie 1A, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France;12. Breast Cancer Unit, MD Anderson Cancer Center Madrid, Madrid, Spain;13. Statistics and Programming, Frontier Science Scotland, Kincraig, UK;14. Medical Department, Breast International Group (BIG) - AISBL, Brussels, Belgium;15. Data Sciences - Data & Statistical Sciences (DSS), Roche Products Limited, Welwyn Garden City, UK;16. Medicine Department, INEN - Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru;17. Clinical Trials and Statistics Unit, ICR - Institute of Cancer Research, London, UK;18. Department of Oncology, Università degli Studi di Milano, Milan, Italy;19. Medical Oncology Department, Instituto Nacional de Cancer - Research Center, Rio de Janeiro, Brazil;20. Institut Jules Bordet, Brussels, Belgium |
